The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatment

Volume: 35, Issue: 10, Pages: 624 - 632
Published: Jun 28, 2019
Abstract
Sorafenib is currently the first-line therapy for advanced hepatocellular carcinoma (aHCC) patients. However, the outcomes and prognostic factors of sorafenib therapy have not been well investigated. We aimed to investigate the pretreatment factors and outcomes among Taiwanese aHCC patients receiving sorafenib treatment. A total of 347 patients with aHCC and well-compensated liver cirrhosis (Child-Pugh A) status receiving sorafenib were...
Paper Details
Title
The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatment
Published Date
Jun 28, 2019
Volume
35
Issue
10
Pages
624 - 632
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.